MicroGenDX, a leader in clinical molecular diagnostics, is launching Rapid H5, a qPCR test designed to detect H5 avian influenza A variants, such as H5N1, the current bird flu strain. Intended for physician use in hospitals, clinics, and other healthcare facilities, the test provides rapid, accurate detection to support patient care, clinical decisions, and H5 influenza case management.…